AI, multiomics help advance endocrine HTN

“This review matters because endocrine hypertension remains one of the few potentially curable forms of hypertension."

Share

1

Endocrine hypertension represents 5-10% of hypertension cases.
2

Primary aldosteronism is often underdiagnosed.
3

AI integration can improve diagnosis and treatment strategies.
4

Less than 1% of hypertensive patients are screened for PA.
5

Challenges include data privacy and clinician training.
6

Multiomics profiling may lead to earlier detection of endocrine hypertension.
7

AI models show diagnostic accuracy nearing traditional methods.
8

Future practice will shift towards data-driven systems.